Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy

A 63-year-old man with metastatic castration-resistant prostate cancer (CRPC) was successfully treated for two years with in situ gene therapy using an adenovirus vector carrying the human REIC/Dkk-3 gene (Ad-REIC), following chemotherapy. Ad-REIC mediates simultaneous induction of cancer-selective...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumon, Hiromi, Sasaki, Katsumi, Ariyoshi, Yuichi, Sadahira, Takuya, Ebara, Shin, Hiraki, Takao, Kanazawa, Susumu, Yanai, Hiroyuki, Watanabe, Masami, Nasu, Yasutomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373706/
https://www.ncbi.nlm.nih.gov/pubmed/25861236
http://dx.doi.org/10.4137/CMO.S23252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373706/
https://www.ncbi.nlm.nih.gov/pubmed/25861236
http://dx.doi.org/10.4137/CMO.S23252

Ejemplares similares